Express Pharma

Siddharth Mehta, Partner – Indirect Tax, KPMG

1

Liberalisation of the input credit regime should give some breather to the industry

In the current budget, the demands of the pharma sector like exemption from excise duty for life saving drugs, correction in the inverted duty structure etc have remained unfulfilled. Liberalisation of the input credit regime, along with simplified compliances under excise should give some breather to the industry.

Comments are closed.